Julie Tierney | Senior Policy Advisor For Strategic Planning And Legislation,Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration (FDA)

Julie Tierney, Senior Policy Advisor For Strategic Planning And Legislation,Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA)

Appearances:



World Orphan Drug Congress USA 2019 - Day 1 @ 11:25

FDA tools to help advance clinical development of cell and gene therapies

last published: 20/Mar/19 21:45 GMT

back to speakers